Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Usha Menon

Showing results (231-240 of 496) with videos related to

Pageof 50
Sort By:
American Journal of Obstetrics and Gynecology|July 11, 2017
Cost-effectiveness of population based BRCA testing with varying Ashkenazi Jewish ancestryRanjit Manchanda, Shreeya Patel, Antonis C Antoniou, et al.
Plos One|December 19, 2009
An epigenetic signature in peripheral blood predicts active ovarian cancerAndrew E Teschendorff, Usha Menon, Aleksandra Gentry-Maharaj, et al.
Journal of the Endocrine Society|December 22, 2017
Radiofrequency Ablation Followed by Percutaneous Ethanol Ablation Leading to Long-Term Remission of HyperparathyroidismMohan T Shenoy, Arun S Menon, P K Nazar, et al.
Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology|May 6, 2024
Outcomes of minimal access retroperitoneal para-aortic lymphadenectomy in patients with locally advanced cervical cancerClaire Newton, Radha Graham, Viola Liberale, et al.
Gynecologic Oncology Reports|April 9, 2024
Ovarian cancer think tank: An overview of the current status of ovarian cancer screening and recommendations for future directionsJulia M Dexter, Lindsay W Brubaker, Benjamin G Bitler, et al.
British Journal of Cancer|July 1, 2017
A combined biomarker panel shows improved sensitivity for the early detection of ovarian cancer allowing the identification of the most aggressive type II tumoursMatthew R Russell, Ciaren Graham, Alfonsina D'Amato, et al.
BMC Proceedings|April 26, 2019
Proceedings of the 2017 Advancing the Science of Community Engaged Research (CEnR) ConferenceAl Richmond, Sergio Aguilar-Gaxiola, Eliséo J Perez-Stable, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 2005
Prospective study using the risk of ovarian cancer algorithm to screen for ovarian cancerUsha Menon, Steven J Skates, Sara Lewis, et al.
Proteomics. Clinical Applications|May 6, 2023
Discovery and validation of serum glycoprotein biomarkers for high grade serous ovarian cancerMriga Dutt, Gunter Hartel, Renee S Richards, et al.
Indian Journal of Endocrinology and Metabolism|April 25, 2019
Role of Procalcitonin as a Predictor of Clinical Outcome in Acute Diabetic Foot Infections: A Prospective StudyAdlyne R Asirvatham, Usha Menon, Praveen V Pavithran, et al.
Pageof 50

Showing results (231-240 of 496) with videos related to

Sort By:
Pageof 50
American Journal of Obstetrics and Gynecology|July 11, 2017
Cost-effectiveness of population based BRCA testing with varying Ashkenazi Jewish ancestryRanjit Manchanda, Shreeya Patel, Antonis C Antoniou, et al.
Plos One|December 19, 2009
An epigenetic signature in peripheral blood predicts active ovarian cancerAndrew E Teschendorff, Usha Menon, Aleksandra Gentry-Maharaj, et al.
Journal of the Endocrine Society|December 22, 2017
Radiofrequency Ablation Followed by Percutaneous Ethanol Ablation Leading to Long-Term Remission of HyperparathyroidismMohan T Shenoy, Arun S Menon, P K Nazar, et al.
Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology|May 6, 2024
Outcomes of minimal access retroperitoneal para-aortic lymphadenectomy in patients with locally advanced cervical cancerClaire Newton, Radha Graham, Viola Liberale, et al.
Gynecologic Oncology Reports|April 9, 2024
Ovarian cancer think tank: An overview of the current status of ovarian cancer screening and recommendations for future directionsJulia M Dexter, Lindsay W Brubaker, Benjamin G Bitler, et al.
British Journal of Cancer|July 1, 2017
A combined biomarker panel shows improved sensitivity for the early detection of ovarian cancer allowing the identification of the most aggressive type II tumoursMatthew R Russell, Ciaren Graham, Alfonsina D'Amato, et al.
BMC Proceedings|April 26, 2019
Proceedings of the 2017 Advancing the Science of Community Engaged Research (CEnR) ConferenceAl Richmond, Sergio Aguilar-Gaxiola, Eliséo J Perez-Stable, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 2005
Prospective study using the risk of ovarian cancer algorithm to screen for ovarian cancerUsha Menon, Steven J Skates, Sara Lewis, et al.
Proteomics. Clinical Applications|May 6, 2023
Discovery and validation of serum glycoprotein biomarkers for high grade serous ovarian cancerMriga Dutt, Gunter Hartel, Renee S Richards, et al.
Indian Journal of Endocrinology and Metabolism|April 25, 2019
Role of Procalcitonin as a Predictor of Clinical Outcome in Acute Diabetic Foot Infections: A Prospective StudyAdlyne R Asirvatham, Usha Menon, Praveen V Pavithran, et al.
Pageof 50